Prevalence of national treatment algorithm defined smear positive pulmonary tuberculosis in HIV positive patients in Brazzaville, Republic of Congo

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Linguissi, Laure Stella Ghoma ^a,b   Mayengue, Pembe Issamou ^a,b   Sidibé, Anissa ^a,b   Vouvoungui, Jeannhey C ^a,b   Missontsa, Mitawa ^a,b   Madzou Laboum, Igor Kevin ^d   Essassa, Gaston Bango ^d   Oyakhirome, Sunny ^a   Frank, Matthias ^c,f   Penlap, Veronique ^e   Ntoumi, Francine ^a,b,c  

^a Fondation Congolaise Pour la Recherche Medicale   (Congo)

^b UNIVERSITÉ MARIEN NGOUABI   (Congo)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Centre Antituberculeux de Brazzaville Programme de Lutte Contre la Tuberculose   (Congo)

^e University Yaoundé1   (Cameroon)

^f HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

HIV infection; Microscopy; Pulmonary TB; Republic of Congo; Tuberculosis

Indexed keywords

ADULT; AIDS RELATED COMPLEX; ALGORITHM; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; COMPLICATION; DEMOCRATIC REPUBLIC CONGO; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; PREVALENCE; TUBERCULOSIS, PULMONARY; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALGORITHMS; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; HUMANS; MALE; PREVALENCE; TUBERCULOSIS, PULMONARY; VIRAL LOAD;

EID: 84907052245     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-578     Document Type: Article

References (46)

1. Burden of New and recurrent tuberculosis in a major south African city stratified by Age and HIV-status. Wood R, Lawn SD, Caldwell J, Kaplan R, Middelkoop K, Bekker L-G, Bekker L-G, PLoS One 2011 6 10 25098 doi:10.1371/journal.pone.0025098 10.1371/journal.pone.0025098 22016763
2. Global tuberculosis control report. World Health Organization, WHO Report 2011 http://www.who.int/tb/publications/global-report/2011/gtbr11-full.pdf. Accessed on 4 July 2013
3. Report on the global AIDS epidemic. UNAIDS, 2012 http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120-UNAIDS-Global-Report-2012-en.pdf, available the 09/07/2013
4. An algorithm for tuberculosis screening and diagnosis in people with HIV. Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, Kanara N, Kimerling ME, Chheng P, Thai S, Sar B, Phanuphak P, Teeratakulpisarn N, Phanuphak N, Nguyen HD, Hoang TQ, Le HT, Varma JK, N Engl J Med 2010 362 8 707 716 10.1056/NEJMoa0907488 20181972
5. Prevention of tuberculosis in people living with HIV. Granich R, Akolo C, Gunneberg C, Getahun H, Williams P, Williams B, Clin Infect Dis 2010 50 Supplement 3 215 S222 doi: 10.1086/651494 20397951
6. WHO, Stop TB Partnership, The Global Plan to Stop TB 2011-2015 Geneva: World Health Organization 2011
7. Encephalitis with infiltration by CD8+ lymphocytes in HIV patients receiving combination antiretroviral treatment. Gray F, Lescure FX, Adle-Biassette H, Polivka M, Gallien S, Pialoux G, Moulignier A, Brain Pathol 2013 doi:10.1111/bpa.12038
8. Can we control tuberculosis in high HIV prevalence settings? Godfrey-Faussett P, Ayles H, Tuberculosis (Edinb) 2003 83 68 76 PMID: 12758192 10.1016/S1472-9792(02)00083-5 12758192
9. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Tolu O, Burke R, Tsekela R, Bangani N, Seldon R, Gideon HP, Wood K, Wilkinson KA, Ottenhoff THM, Wilkinson RJ, Thorax 2011 66 8 669 673 10.1136/thx.2011.160168 21632522
10. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Corbett EL, Marston B, Churchyard GJ, De Cock KM, Lancet 2006 367 926 937 10.1016/S0140-6736(06)68383-9 16546541
11. Tuberculosis country profile: Congo. World Health Organization, 2013 https://extranet.who.int/sree/Reports?op=Replet&name=%2FWHO-HQ-Reports%2FG2%2FPROD%2FEXT%2FTBCountryProfile&ISO2=CG&LAN=EN&outtype=html. Accessed on 01 July 2013
12. Tuberculosis and HIV coinfection. Gray JM, Cohn DL, Semin Respir Crit Care Med 2013 34 1 32 43 doi:10.1055/s-0032-1333469. Epub 2013 Mar 4 10.1055/s-0032-1333469 23460004
13. Comparison of acid-fast bacilli smear and chromatographic immunoassay in patients with active tuberculosis. Martínez-Romero A, Ortega-Sánchez JL, González-Yañez MG, Hernández-Salgado JR, Ruíz-Baca E, Alba-Romero JJ, Cervantes-Flores M, Afr J Microbiol Res 2012 6 8 1690 1693
14. Sputum smear negative pulmonary tuberculosis: sensitivity and specificity of diagnostic algorithm. Swai HF, Mugusi FM, Mbwambo JK, BMC Res Notes 2011 4 475 10.1186/1756-0500-4-475 22044882
15. The diagnosis of tuberculosis. Brodie D, Schluger NW, Clin Chest Med 2005 26 247 271 10.1016/j.ccm.2005.02.012 15837109
16. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the xpert MTB/RIF assay: a prospective study. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R, PLoS Med 2011 8 7 1001067 doi:10.1371/journal.pmed.1001067 10.1371/journal.pmed.1001067 21818180
17. Clinical research and development of tuberculosis diagnostics: moving from silos to synergy. Nahid P, Kim PS, Evans CA, Alland D, Barer M, Diefenbach J, Ellner J, Hafner R, Hamilton CD, Iademarco MF, Ireton G, Kimerling ME, Lienhardt C, MacKenzie WR, Murray M, Perkins MD, Posey JE, Roberts T, Sizemore C, Stevens WS, Via L, Williams SD, Yew WW, Swindells S, J Infect Dis 2012 205 159 S168 10.1093/infdis/jis194 22476718
18. HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis. Mugusi F, Villamor E, Urassa W, Saathoff E, Bosch RJ, Fawzi WW, Int J Tuberc Lung Dis 2006 10 663 669 16776454
19. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. Harries AD, Zachariah R, Lawn SD, Int J Tuberc Lung Dis 2009 13 1 6 16 19105873
20. Risk factors for tuberculosis. Pulmonary medicine. Padmanesan N, Wood J, MacIntyre CR, Mathai D, 2013 2013 Article ID 828939. http://www.readcube.com/articles/10.1155/2013/828939?locale=en
21. The risk and timing of tuberculosis diagnosed in smear-negative TB suspects: a 12 month cohort study in Harare, Zimbabwe. Dimairo M, MacPherson P, Bandason T, Zezai A, Munyati SS, Butterworth AE, Mungofa S, Rusikaniko S, Fielding K, Mason PR, Corbett EL, PLoS One 2010 5 7 11849 doi:10.1371/journal.pone.0011849 10.1371/journal.pone.0011849 20676374
22. Are routine tuberculosis programme data suitable to report on antiretroviral therapy use of HIV-infected tuberculosis patients? Brouwer M, Gudo PS, Simbe CM, Perdigão P, Van Leth F, BMC Rese Notes 2013 6 23 doi:10.1186/1756-0500-6-23 10.1186/1756-0500-6-23
23. Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. Dowdy DW, Lourenço MC, Cavalcante SC, Saraceni V, King B, Golub JE, Bishai D, Durovni B, Chaisson RE, Dorman SE, PLoS One 2008 3 12 4057 doi:10.1371/journal.pone.0004057 10.1371/journal.pone.0004057 19129940
24. HIV-associated tuberculosis: clinical update. Soumya S, Padmapriyadarsini C, Narendran G, Clin Infect Dis 2010 50 10 1377 1386 doi:10.1086/652147 10.1086/652147 20388036
25. Survival among patients with HIV infection and smear-negative pulmonary tuberculosis-United States, 1993-2006. Cavanaugh JS, Shah NS, Cain KP, Winston CA, PLoS One 2012 7 10 47855 doi:10.1371/journal.pone.0047855 10.1371/journal.pone.0047855 23110113
26. Association of BMI category change with TB treatment mortality in HIV-positive smear-negative and extrapulmonary TB patients in Myanmar and Zimbabwe. Benova L, Fielding K, Greig J, Nyang'wa B-T, Casas EC, da Fonseca, du Cros P, PLoS One 2012 7 4 35948 doi:10.1371/journal.pone.0035948 10.1371/journal.pone.0035948 22545150
27. Diagnosis & treatment of tuberculosisin HIV co-infected patients. Padmapriyadarsini G, Swaminathan N, Swaminathan S, Indian J MedRes 2011 134 850 865 10.4103/0971-5916.92630
28. Use of mycobacteriophage qPCR on MGIT broths for a rapid tuberculosis antibiogram. Foongladda S, Klayut W, Chinli R, Pholwat S, Houpt ER, J Clin Microbiol 2014 52 1523 1528 doi:10.1128/JCM.03637-13. 10.1128/JCM.03637-13 24574299
29. Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. Lawn SD, Wood R, J Infect Dis 2011 204 suppl 4 1159 S1167 doi:10.1093/infdis/jir411 10.1093/infdis/jir411 21996698
30. Factors associated with delayed diagnosis of tuberculosis in hospitalized patients in a high TB and HIV burden setting: a cross-sectional study. Rossato Silva D, Müller AM, Tarso Roth Dalcin DP, BMC Infect Dis 2012 12 57 doi:10.1186/1471-2334-12-57 10.1186/1471-2334-12-57 22420509
31. HIV-associated tuberculosis: a sub-Saharan African perspective. Adeiza MA, Abba AA, Okpapi JU, 2014 1 1 1 14
32. Natural history and factors associated with early and delayed mortality in HIV-infected patients treated of tuberculosis under directly observed treatment short-course strategy: a prospective cohort study in India. Alvarez-Uria G, Naik PK, Pakam R, Bachu L, Midde M, Interdiscip Perspect Infect Dis 2012 2012 Article ID 502012, 9 pages. http://dx.doi.org/10.1155/2012/502012
33. Sputum smear microscopy in tuberculosis: is it still relevant? Desikan P, Indian J Med Res 2013 137 442 444 23640550
34. New diagnostic tools for tuberculosis. Perkins MD, Int J Tuberc Lung Dis 2000 12 2 182 S188
35. Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting. Huerga H, Varaine F, Okwaro E, Bastard M, Ardizzoni E, Sitienei J, Chakaya J, Bonnet M, PLoS One 2012 7 12 51336 doi:10.1371/journal.pone.0051336 10.1371/journal.pone.0051336 23284681
36. High prevalence of pulmonary tuberculosis but Low sensitivity of symptom screening among HIV-infected pregnant women in South Africa. Hoffmann CJ, Variava E, Rakgokong M, Masonoke K, van der Watt M, Chaisson RE, Martinson NA, PLoS One 2013 8 4 62211 doi:10.1371/journal.pone.0062211 10.1371/journal.pone.0062211 23614037
37. Clinical and radiographic factors Do Not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study. Davis JL, Worodria W, Kisembo H, Metcalfe JZ, Cattamanchi A, Kawooya M, Kyeyune R, den Boon S, Powell K, Okello R, Yoo S, Huang L, PLoS One 2010 5 3 9859 10.1371/journal.pone.0009859 20361038
38. Immune reconstitution inflammatory syndrome: a reappraisal. Mayer K, Clin Infect Dis 2009 48 1 101 107 doi:10.1086/595006 10.1086/595006 19025493
39. Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS clinical trials group protocol A5253. Swindells S, Komarow L, Tripathy S, Cain KP, MacGregor RR, Achkar JM, Gupta A, Veloso VG, Asmelash A, Omoz-Oarhe AE, Gengiah S, Lalloo U, Allen R, Shiboski C, Andersen J, Qasba SS, Katzenstein DK, AIDS Clinical Trials Group 5253 Study Team, Int J Tuberc Lung Dis 2013 17 4 532 539 doi:10.5588/ijtld.12.0737 10.5588/ijtld.12.0737 23485388
40. Evaluation of a diagnostic algorithm for sputum smear-negative pulmonary tuberculosis in HIV-infected adults. Narendran G, Selvakumar N, Risbud AR, Sheta D, Rajasekaran S, Thomas A, Wares F, Swaminathan S, J Acquir Immune Defic Syndr 2013 63 3 331 338 doi:10.1097/QAI.0b013e31829341af 10.1097/QAI.0b013e31829341af 23599010
41. Tuberculosis diagnostics xpertmtb/Rif test. World Health Organization, WHO Endorsement and Recommendations 2010 http://www.who.int/tb/features-archive/factsheet-xpert-may2011update.pdf. Accessed on July 3, 2013
42. Evaluation of the xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection Are highly endemic. O'Grady J, Bates M, Chilukutu L, Mzyece J, Cheelo B, Chilufya M, Mukonda L, Mumba M, Tembo J, Chomba M, Kapata N, Maeurer M, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A, Clin Infect Dis 2012 55 9 1171 1178 doi:10.1093/cid/cis631 10.1093/cid/cis631 22806590
43. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N, Cochrane Database Syst Rev 2013 1 Art. No.: CD009593. doi:10.1002/14651858.CD009593.pub2
44. A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru. Carriquiry G, Otero L, González-Lagos E, Zamudio C, Sánchez E, Nabeta P, Campos M, Echevarría J, Seas C, Gotuzzo E, PLoS One 2012 7 9 44626 doi:10.1371/journal.pone.0044626 10.1371/journal.pone.0044626 22970271
45. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lawn SD, Kerkhoff AD, Vogt M, Wood R, Lancet Infect Dis 2012 12 3 201 209 doi:10.1016/S1473-3099(11)70251-1. Epub 2011 Oct 17 10.1016/S1473-3099(11)70251-1 22015305
46. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. Lawn SD, BMC Infect Dis 2012 12 103 doi:10.1186/1471-2334-12-103. Review 10.1186/1471-2334-12-103 22536883